purple-logo2020.png
Purple Biotech Reports Third Quarter 2022 Financial Results
08 nov. 2022 07h53 HE | Purple Biotech Ltd.
Well capitalized with cash runway through 2024 Clinical progress for both programs, CM24 and NT219 REHOVOT, Israel, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the...
Impulse Dynamics Announces 7,000th Patient Treated With CCM Reinforcing Significant Clinical Experience
26 avr. 2022 09h00 HE | Impulse Dynamics
MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce a...
Impulse Dynamics' Quality Management System Receives Certification Under European Union Medical Device Regulation
22 mars 2022 09h00 HE | Impulse Dynamics
MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, is pleased to announce that it has successfully completed...
Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population
14 mars 2022 09h42 HE | Impulse Dynamics
MARLTON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first...
Deep Drawing Specialist STÜKEN North America Announces First Steps Towards ISO 13485 Certification
07 mars 2022 07h46 HE | Stueken, LLC
FOUNTAIN INN, S.C., March 07, 2022 (GLOBE NEWSWIRE) -- Miniaturization and standardization have been driving the rising demand for deep-drawn metal components in the medical industry. STÜKEN North...
IMPULSE DYNAMICS ANNOUNCES FIRST OPTIMIZER IMPLANT IN CHINA
01 nov. 2021 08h23 HE | Impulse Dynamics
MARLTON, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, today announced the first...
IMPULSE DYNAMICS RECEIVES FDA APPROVAL TO MODIFY LABELING FOR OPTIMIZER SMART MEDICAL DEVICES
26 oct. 2021 08h57 HE | Impulse Dynamics
MARLTON, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the U.S....
Diazyme
Diazyme Laboratories, Inc. Receives Second FDA EUA for COVID-19 Antibody Test
17 août 2020 20h09 HE | General Atomics
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgM CLIA test. The Diazyme IgM test runs on...
blank.JPG
Diazyme Laboratories, Inc. Announces Partnership for COVID-19 Molecular Diagnostics Test
30 juil. 2020 16h06 HE | General Atomics
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Diazyme announces partnership with Maccura Biotechnology (USA) LLC, launching a FDA EUA approved SARS-COV-2 RT-PCR diagnostics test.  “Here at Diazyme,...
blank.JPG
Diazyme Laboratories, Inc. Receives FDA EUA for COVID-19 Antibody Test
08 juil. 2020 20h32 HE | General Atomics
SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgG CLIA test. The Diazyme IgG test is run on...